Varsha Gandhi Selected Research

8-aminoadenosine

12/2010	8-Aminoadenosine inhibits Akt/mTOR and Erk signaling in mantle cell lymphoma.
3/2010	Chain termination and inhibition of mammalian poly(A) polymerase by modified ATP analogues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Varsha Gandhi Research Topics

Disease

59	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 09/2005
56	Neoplasms (Cancer) 01/2023 - 01/2002
26	Leukemia 11/2023 - 02/2002
26	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2022 - 02/2002
20	Multiple Myeloma 06/2017 - 08/2002
17	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 12/2003
11	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2023 - 06/2002
9	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2021 - 11/2009
8	Lymphoma (Lymphomas) 01/2023 - 01/2002
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2014 - 10/2003
6	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 10/2005
6	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 08/2012 - 10/2003
5	Disease Progression 01/2022 - 02/2012
5	Purine Nucleoside Phosphorylase Deficiency 01/2017 - 12/2005
4	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 11/2023 - 08/2013
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 01/2013
4	Breast Neoplasms (Breast Cancer) 10/2018 - 06/2010
3	Lymphopenia (Lymphocytopenia) 08/2013 - 12/2007
2	Residual Neoplasm 01/2021 - 03/2011
2	Exanthema (Rash) 01/2018 - 11/2017
2	Diarrhea 01/2018 - 06/2014
2	Blast Crisis (Blast Phase) 08/2012 - 02/2005
2	T-Lymphocytopenia 10/2006 - 12/2005
1	Starvation 11/2023
1	B-Cell Leukemia (Leukemia, B Cell) 01/2023
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2023
1	RNA Virus Infections 10/2022
1	COVID-19 10/2022

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2002
21	NucleosidesIBA 01/2023 - 08/2002
20	Phosphotransferases (Kinase)IBA 07/2021 - 06/2002
20	Clofarabine (Clolar)FDA Link 01/2018 - 03/2003
15	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 10/2002
14	ibrutinibIBA 01/2022 - 02/2012
11	venetoclaxIBA 01/2023 - 08/2015
11	fludarabineIBA 12/2021 - 01/2002
10	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 01/2002
10	triphosphoric acid (triphosphate)IBA 03/2010 - 06/2002
9	RNA (Ribonucleic Acid)IBA 11/2023 - 11/2003
8	Purine-Nucleoside PhosphorylaseIBA 01/2017 - 12/2005
7	ProdrugsIBA 01/2023 - 05/2002
7	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 02/2012
7	Adenosine Triphosphate (ATP)IBA 01/2022 - 06/2005
6	proto-oncogene proteins pimIBA 01/2018 - 11/2009
6	forodesineIBA 08/2013 - 12/2005
5	nelarabine (506U78)FDA Link 01/2023 - 06/2002
5	Purine NucleosidesIBA 01/2023 - 04/2005
5	Bendamustine Hydrochloride FDA Link 03/2017 - 08/2002
5	8-chloroadenosineIBA 01/2015 - 09/2009
5	SGI 1776IBA 09/2013 - 11/2009
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 09/2007
4	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2018 - 12/2011
4	Arabinofuranosylcytosine TriphosphateIBA 01/2018 - 10/2002
4	idelalisibIBA 03/2017 - 04/2015
4	Adenosine (Adenocard)FDA LinkGeneric 01/2015 - 06/2005
4	Messenger RNA (mRNA)IBA 09/2013 - 06/2005
4	deoxyguanosine triphosphate (dGTP)IBA 08/2013 - 12/2003
3	NucleotidesIBA 11/2023 - 03/2009
3	tapotoclaxIBA 01/2023 - 01/2020
3	Rituximab (Mabthera)FDA Link 12/2021 - 04/2015
3	AZD1208IBA 04/2019 - 12/2016
3	9-arabinofuranosylguanineIBA 01/2017 - 06/2002
3	Apoptosis Regulatory ProteinsIBA 01/2017 - 01/2016
3	GuanosineIBA 01/2017 - 09/2003
3	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 04/2014 - 12/2003
3	Tyrosine (L-Tyrosine)FDA Link 09/2013 - 07/2009
3	Cladribine FDA LinkGeneric 07/2006 - 10/2002
3	Gemcitabine FDA Link 08/2004 - 02/2002
2	GlutaminaseIBA 01/2023 - 01/2019
2	Protein Kinases (Protein Kinase)IBA 01/2021 - 04/2012
2	EstersIBA 10/2018 - 07/2012
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2018 - 11/2017
2	Transaminases (Aminotransferases)IBA 11/2017 - 06/2014
2	ARQ 197IBA 06/2017 - 03/2015
2	duvelisibIBA 05/2017 - 01/2017
2	Protein Isoforms (Isoforms)IBA 05/2017 - 12/2006
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2013
2	Ursolic AcidIBA 11/2016 - 11/2016
2	carfilzomibIBA 09/2016 - 01/2015
2	Caspase 3 (Caspase-3)IBA 01/2016 - 11/2015
2	pyrimidineIBA 08/2015 - 11/2002
2	bcr-abl Fusion ProteinsIBA 04/2014 - 11/2006
2	Threonine (L-Threonine)FDA Link 09/2013 - 10/2012
2	Serine (L-Serine)FDA Link 09/2013 - 10/2012
2	8-aminoadenosineIBA 12/2010 - 03/2010
2	N- (5- (((5- (1,1- dimethylethyl)- 2- oxazolyl)methyl)thio)- 2- thiazolyl)- 4- piperidinecarboxamideIBA 08/2010 - 05/2009
2	EnzymesIBA 08/2010 - 12/2005
2	purineIBA 08/2010 - 11/2003
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 03/2009 - 12/2006
2	9-beta-D-arabinofuranosylguanosine 5'-triphosphateIBA 03/2008 - 06/2002
1	Dihydroorotate DehydrogenaseIBA 11/2023
1	CB-839IBA 01/2023
1	AZD5991IBA 01/2023
1	Dipyridamole (Persantine)FDA LinkGeneric 10/2022
1	brequinarIBA 10/2022
1	Antiviral Agents (Antivirals)IBA 10/2022

Therapy/Procedure

27	Therapeutics 01/2023 - 02/2002
7	Drug Therapy (Chemotherapy) 01/2023 - 12/2011
2	Intravenous Infusions 02/2005 - 12/2003